Fundraising Fox

Avital Adler

Investor

Analyst at aMoon

Tel Aviv, Israel

Writes $100K – $5M checks Β· typically $1.5M

About

Avital Adler is a principal at Arkin Bio Ventures within Arkin Capital, where she leads early and late-stage investments. She previously spent four years at aMoon as a scientific and business diligence lead for biotech and diagnostics investments and helped establish aMoon Edge, the firm's public markets platform. Adler holds a PhD in Neural Computation from the Hebrew University, conducted postdoctoral research at NYU Medical Center, and has authored 21 peer-reviewed publications.

Experience

  1. Arkin CapitalPrincipal, Arkin Bio Venturescurrent2025 β€” present
  2. Self-employedHealthTech / BioTech Investor and Consultant2024 β€” 2025
  3. aMoon FundPrincipal2023 β€” 2024
  4. aMoon FundAssociate2022 β€” 2023
  5. aMoon FundScientific Analyst2020 β€” 2022Israel
  6. AltruBio Inc.Board Observer2021 β€” 2024
  7. NYU Langone Medical CenterPostdoctoral Fellow2013 β€” 2020Greater New York City Area
  8. Hebrew UniversityPHD, Hebrew University Medical School2007 β€” 2013Jerusalem, Israel
  9. Hebrew UniversityTeaching Assistant, Hebrew University Medical School2006 β€” 2012

Education

  1. The Hebrew University of JerusalemDoctor of Philosophy - PhD, Neuroscience / Neural Computation2010 β€” 2013
  2. The Hebrew University of JerusalemMaster of Science - MS, Neuroscience / Neural Computation2007 β€” 2010
  3. Tel Aviv UniversityBachelor of Science - BS, Double-Major inBiology and Psychology2001 β€” 2004

Same school

Shared employers

Colleagues at aMoon

Network5

Investors connected to Avital in public investor directories β€” a warm-intro map.